The Impact of a New Interleukin-2-Based Immunotherapy Candidate on Urothelial Cells to Support Use for Intravesical Drug Delivery

(1) Background: The intravesical instillation of interleukin-2 (IL-2) has been shown to be very well tolerated and promising in patients with bladder malignancies. This study aims to confirm the use of a new IL-2 containing immunotherapy candidate as safe for intravesical application. IL-2, produced...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitz, Lisa, Berdien, Belinda, Huland, Edith, Dase, Petra, Beutel, Karin, Fisch, Margit, Engel, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601792/
https://www.ncbi.nlm.nih.gov/pubmed/33027905
http://dx.doi.org/10.3390/life10100231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601792/
https://www.ncbi.nlm.nih.gov/pubmed/33027905
http://dx.doi.org/10.3390/life10100231

Ejemplares similares